Daniel C. Martin - Jun 16, 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Commercial Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jun 16, 2022
Transactions value $
-$14,093
Form type
4
Date filed
6/21/2022, 04:35 PM
Previous filing
Feb 18, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$14.1K -1.31K -2.58% $10.75 49.5K Jun 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.
F2 Includes 2,164 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2022.